Scotty, in case you did not notice, many longs are pretty certain NWBO is not doing anything right now to increase the share price. Right now, Tocan, Cognate, NWBO management and close friends probably account for about 1/3 to 1/2 of the 1.1 billion or so options, warrants and shares. They are clearly positioned to do well if the company sells out or the results on DCVax-L are excellent. Meanwhile, the price remains low, and one can only guess sweetheart deals continue to finance this company, whether it be LP herself, or friendly financiers. Long in tooth retail either could or could not keep up under these prices unless they continually recommit to a level of risk above and beyond that of those in the know. In the end, the less of us (public retail) there are, the cheaper management can sell to BP while management still makes a whopping amount of money if results are good. I see nothing but financial incentive from buyer and seller to scrape us off the bottom of their shoes -- and not attract unknown newbie retail.
News 
Market Data 
Discover 
AI
